CUSIP: 30233M107
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,529,808
-
Share change
-
+254,504
-
Total reported value
-
$5,436,000
-
Price per share
-
$0.31
-
Number of holders
-
19
-
Value change
-
+$51,789
-
Number of buys
-
9
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2018
-
Previous quarter:
Q2 2018
Recent filing periods for CUSIP 30233M107:
Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q3 2018
As of 30 Sep 2018,
EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,529,808 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Vanguard Group Inc, PANAGORA ASSET MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, BARCLAYS PLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, MILLENNIUM MANAGEMENT LLC, US BANCORP \DE\, and CITADEL ADVISORS LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.